1. |
Machado RD, Southgate L, Eichstaedt CA, et al. Pulmonary arterial hypertension: a current perspective on established and emerging molecular genetic defects. Hum Mutat, 2015, 36(12): 1113-1127.
|
2. |
. Machado RD, Eickelberg O, Elliott CG, et al. Genetics and genomics of pulmonary arterial hypertension. J Am Coll Cardiol, 2009, 54(1 Suppl): S32-S42.
|
3. |
Han C, Hong KH, Kim YH et al. SMAD1 deficiency in either endothelial or smooth muscle cells can predispose mice to pulmonary hypertension. Hypertension, 2013, 61(5): 1044-1052.
|
4. |
王秋菊, 沈亦平, 陈少科, 等. 遗传变异分类标准与指南. 中国科学:生命科学, 2017, 47(6): 668.
|
5. |
Richards S, Aziz N, Bale S et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med, 2015, 17(5): 405-424.
|
6. |
Machado RD, Rudarakanchana N, Atkinson C, et al. Functional interaction between BMPR-Ⅱ and Tctex-1, a light chain of Dynein, is isoform-specific and disrupted by mutations underlying primary pulmonary hypertension. Hum Mol Genet, 2003, 12(24): 3277-3286.
|
7. |
Tsang HT, Edwards TL, Wang X et al. The hereditary spastic paraplegia proteins NIPA1, spastin and spartin are inhibitors of mammalian BMP signalling. Hum Mol Genet, 2009, 18(20): 3805-3821.
|
8. |
Davis BN, Hilyard AC, Lagna G, et al. SMAD proteins control DROSHA-mediated microRNA maturation. Nature, 2008, 454(7200): 56-61.
|
9. |
Drake KM, Zygmunt D, Mavrakis L, et al. Altered MicroRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8. Am J Respir Crit Care Med, 2011, 184(12): 1400-1408.
|
10. |
Sawada H, Saito T, Nickel NP et al. Reduced BMPR2 expression induces GM-CSF translation and macrophage recruitment in humans and mice to exacerbate pulmonary hypertension. J Exp Med, 2014, 211(2): 263-280.
|
11. |
Evans JD, Girerd B, Montani D, et al. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis. Lancet Respir Med, 2016, 4(2): 129-137.
|
12. |
Elliott CG, Glissmeyer EW, Havlena GT, et al. Relationship of BMPR2 mutations to vasoreactivity in pulmonary arterial hypertension. Circulation, 2006, 113(21): 2509-2515.
|